Tuesday, November 29, 2022
HomeNationalAzad sharpens attack on Gandhi

Azad sharpens attack on Gandhi


Veteran politician Ghulam Nabi Azad, who has been associated with Indian National Congress for over five decades, quit the grand old party last week, giving rude jolt to the party. Azad was considered an indispensable part of Congress party and played crucial role within the party and also in UPA Governments. He was considered the blue-eyed boy of Gandhis. But relationships strained between Azad and Gandhis over the last few years, finally leading to his resignation from the party. 

Azad’s resignation from Congres party not only shook Congress cadres but created interest among all political parties. Because this was seen as a move, which will further weaken the struggling Congress party and will also impact highly sensitive Kashmir politics.

In his resignation letter, Azad mostly blamed Congress scion Rahul Gandhi for the sorry state of affairs in Congress. Speaking to media for the first time after resigning from Congress party on Monday, Azad once again attacked Rahul Gandhi. Interacting with reporters in New Delhi, Ghulam Nabi Azad said that he quit Congress party with a heavy heart. He added that he was forced to resign as Gandhis turned cold feet towards him, after G-23 letter. Stepping up his attack on Rahul Gandhi, the senior leader said that everyone in Congress worked hard to make Rahul Gandhi a leader but younger Gandhi was never interested in it. He stressed that Congress party under Rahul Gandhi’s leadership will soon crumble. 

More like this

Love Today 2 days collections in AP & TS

Love Today is a Tamil-language romantic comedy entertainer, directed...

Itlu Maredumilli Prajaneekam 2 days box office collections

Allari Naresh's recently released social drama Itlu Maredumilli Prajaneekam...

Netflix announces Love Today OTT release date

Youthful entertainer Love Today, which was released on November...

75% with hypertension in India have uncontrolled BP

According to a study in medical journal The Lancet...

Top Stories